NCI-Designated Cancer Centers Endorse Goal of Eliminating HPV-Related Cancers
The 70 National Cancer Institute (NCI)-designated cancer centers underscored the importance of increased HPV vaccination and evidence-based screening, with the goal of eliminating cancers caused by the human papillomavirus (HPV).
Recognizing the prevalence of cancers caused by the human papillomavirus (HPV) as a significant public health problem, the nation’s top cancer centers
The joint statement from the 70 National Cancer Institute (NCI)-designated cancer centers underscores the importance of increased HPV vaccination and evidence-based screening, with the goal of eliminating cancers caused by the virus.
“All 70 cancer centers, representing the nation’s leaders in cancer care and research, perceive low vaccination rates as a public health threat and call upon physicians, patients, and young adults to take advantage of this opportunity to prevent several types of cancer in men and women,” states a
In particular, people living with HIV
In alignment with the Healthy People 2020 Initiative, the statement called for:
- Vaccination of more than 80% of males and females ages 13-15 by 2020
- Screening of 93% of age-eligible females for cervical cancer by 2020
- Prompt followup and proper treatment of females who screen positive for high-grade cervical pre-cancerous lesions
They also recommend that men and women up to age 26 complete the recommended vaccine series; healthcare providers make clear and strong recommendations for HPV vaccination and cervical screening; and healthcare community members educate parents, guardians, community members, and colleagues about the goal of eliminating HPV-related cancers.
The statement estimates that increased rates of vaccination and evidence-based cancer screening can prevent 12,000 cervical cancers and nearly 40,000 other HPV-related cancers. “Increased HPV vaccination rates combined with appropriate cervical cancer screening measures could soon eliminate cervical cancer, with other HPV-related cancers in males and females to follow,” reads the statement.
In addition to the 70 cancer centers, the American Cancer Society, the American Association for Cancer Research, the American Society for Clinical Oncology, the Prevent Cancer Foundation, the American Society for Preventive Oncology, and the Association of American Cancer Institutes endorsed the statement.
This is the third national call to action from the NCI-designated cancer centers, with the fisrt statement published in 2016.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025